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Abstract: The protein p53 seems to be related to the suppression of cell proliferation. Positive tissues appear to have a higher
proliferative activity than negative tissues.
Mutation of the p53 tumour suppressor gene has been demonstrated in a large proportion of human head and neck tumours,
although no formal evidence of functional aberration has been shown p53 may have importance during the early stage of malignancy.
The aim of this study was to evaluate the role of the p53 tumour suppressor gene in the pathogenesis of odontogenic cysts.
Expression of abnormal p53 protein is a widely recognised marker of malignancy.
Expression of p53 was evaluated immunohistochemically in a retrospective study of formalin-fixed, paraffin-embedded tissue. Forty
cases of odontogenic cysts were examined for expression of p53 protein by a immunohistochemical technique and positive results
of the p53 protein were demonstrated by nuclear staining.
Twenty-seven of 40 odontogenic cyst cases were positive for p53 protein. The differences between the groups were statistically
significant (P = 0.02).
The incidence of p53 protein nuclear accumulation detected by immunohistochemistry is high in odontogenic lesions. The present
data indicate that p53 inactivation plays a role both in the initiation and in the progression of odontogenic cysts.
Key Words: Odontogenic cysts, p53 protein, immunohistochemistry.

Introduction
Two types of gene have been implicated in the
development of the malignant phenotype. The first type
is proto-oncogenes, which become activated in response
to various mitogenic signals (1-4).
When mutated they become oncogenes (or cancercausing genes) and give rise to proteins which lead to
abnormal cell growth. Altered expression of single
oncogenes is generally insufficient to induce full
transformation and in most cases activation of several
oncogenes contributes to the tumourogenic process. The

second type of genes implicated in the pathogenesis of the
malignant phenotype is the tumour suppressor genes,
encoding proteins which have the ability to suppress cell
division (1-5).
During tumour development, tumour suppressor
genes often become mutated or deleted and lose their
normal function, which is to negatively regulate cell
growth. These genes may play a more important role in
the development of neoplasia than oncogenes (1-5).
The p53 gene on chromosome 17 is a tumour
suppressor gene and mutation is common to a wide range
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of human tumours and a frequent step in neoplastic
transformation (1-4).
The p53 protein is present in extremely low
concentrations in normal cells, owing to its very short
half-life and it is virtually undetectable by
immunohistochemical techniques. Hence, the ability to
detect the protein in tumours is probably synonymous
with the presence of a mutation since mutation has been
shown to be a stable protein that accumulates in cells,
allowing it to be detected immunohistochemically (1-6).
Numerous studies have reported the presence of p53
protein in human tumours by immunostaining histological
sections and this has been considered to reflect the
presence of a p53 mutation (3,4,6-8).
Furthermore, a more recent study of preneoplastic
and neoplastic lesions of the oral mucosa has shown that
p53 overexpression is related to increasing dysplasia and
loss of differentiation during the development of oral
malignancy (2-4,6).
The aim of the present study was to
immunohistochemically evaluate the expression of p53
protein in different types of odontogenic cysts.
We have now immunostained a larger series of
odontogenic cysts with the mouse monoclonal antibody
D07 to determine whether p53 expression correlates
with histological features.
Materials and Methods
Surgical specimens from 40 cases of odontogenic
cysts were fixed in 10% formalin and embedded in
paraffin according to standard procedures. Sections were
stained with haematoxylin and eosin and examined
histopathologically.
The lesions which were histopathologically examined
consisted of 11 keratocysts, nine radicular cysts and 20
dentigerous cysts. A total of 40 individuals, 19 male and
21 female aged between 12 and 62 with a total of 40
odontogenic cysts (20 localised in the maxilla and 20 in
the mandible) were investigated. The diameter of the
cysts varied between 0.8 cm and 6.0 cm. Then
representative sections were immunostained for p53
protein.
Descriptive statistical analysis was performed for each
group of lesions and a chi-square test was used to show
statistically significant differences between the groups.
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Immunohistochemistry
All samples were formalin-fixed, paraffin-embedded
tissue blocks. Each tissue block was sectioned serially into
5-mm-thick pieces and these were put on to poly-L-lysine
coated slides. Sections were deparaffinized and
rehydrated with distilled water. For the microwave
antigen retrieval method, sections were immersed in 75
ml of citrate buffer and irradiated in a domestic
microwave oven at full power (750 W) for 2 x 5 min.
Microwaved sections were incubated for a further 20 min
in the hot buffer and put into phosphate buffered saline
(PBS; pH 7.6).
In the immunohistochemical analysis, anti-p53
monoclonal prediluted antibody (p53 D07, Dako), HRP
labelled streptavidin-biotin (LSAB HRP, Dako) system and
AEC chromogen (3% 3-amino-9-ethylcarbazole) were
used.
The primary antibody was applied for 30 min at room
temperature. Chromatogens were stained with
haematoxylin and examined under a light microscope.
A positive control specimen, which was an oral
squamous cell carcinoma before being determined as p53
positive, was used to standardise the procedure between
batches. For negative control tests, nonimmunised mouse
sera were used and the primary antibody was omitted.
The staining of all sections was evaluated by two
independent observers and the intensity of nuclear
staining was graded as (-) negative, (+) weak staining,
(++) moderate staining or (+++) strong staining.
Results
In our research, p53 immunostaining results of
odontogenic cysts were compared: in 13 (-) staining was
detected, and in 27 (+). Positive staining for p53 protein
was noted in 10/11 keratocysts (99%), 4/9 radicular
cysts (45%) and 13/20 dentigerous cysts (65%) (Table
1).
p53-positive cells in radicular cysts and odontogenic
keratocysts were diffuse in the parabasal layers (Figs. 12) .
In dentigerous cysts the p53 positivity was mainly
located in the basal layers as generally focal and
odontogenic epithelial islands (Figs. 3-4).
The differences between the groups were statistically
significant (P = 0.02).
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Table 1. Immunostaining results of odontogenic cyst with antibody to p53.

IMMUNOSTAINING WITH ANTIBODY TO
P53
LESIONS

NUMBER OF CASES

(-)

(+)

( ++ )

( +++ )

RANGE

ODONTOGENIC KERATOCYSTS

11

1

1

6

3

10 / 11

RADICULAR CYSTS

9

5

1

1

2

4/9

DENTIGEROUSCYSTS

20

7

6

4

3

13 / 20

TOTAL

40

13

27

Figure 1. Diffuse positive p53 nuclear staining in the parabasal layers
of the epithelial lining of an odontogenic keratocyst (D07,
LSAB; x250).

Figure 2. Diffuse positive p53 nuclear staining in the parabasal layers
of the epithelial lining of a radicular cyst (D07, LSAB; x250).

Figure 3. Focal positive p53 nuclear staining in the odontogenic
epithelium of a dentigerous cyst .(D07, LSAB; x400).

Figure 4. Focal positive p53 nuclear staining in the odontogenic
epithelium of an odontogenic cyst. (D07, LSAB; x1000).
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The nuclei of the positive control cells were positive
and the negative controls were non-reactive.

Discussion
An increase in cell proliferation probably plays a role
in the development of odontogenic cysts and tumours (913). p53 protein probably has a role in the regulation of
the transcription of genes that suppress cell proliferation
(9-12). Wild-type p53 protein acting as a tumour
suppressor down-regulated cell growth, but mutation in
p53 can inactive its tumour suppressor activity, allowing
the dominant oncogenic factor to cause malignant
transformation (6-8,9-14).
The p53 protein is normally expressed at low levels in
non-transformed cells; however, elevated expression was
found in many tumour and cells lines (3,4).
It
was
previously
considered
that
immunohistochemical detection of p53 protein is possible
only when the protein is overexpressed or accumulates in
cells as a result of mutation. Therefore, p53
immunostaining has been used as a marker of neoplasia,
malignancy and tumour progression (1-6).
Many studies have shown that mutations of the p53
tumour suppressor gene are frequently detected genetic
alterations in human cancers (3-4,6-8).
Alterations in the p53 gene have been proposed as
one of the major factors responsible for both the
initiation and progression of oral cancer. Both loss of
heterozigosity and point mutations of the p53 gene have
been reported to occur in oral cancer. A moderate to high
prevalence of p53 overexpression in upper aerodigestive
tract squamous cell carcinomas has been found (3-6,8).
Thus, mutation of the p53 gene may be considered a
prevalent finding in malignancies in the oral mucosa and
the head and neck region (1-3,5-6). p53-positive tissue
seems to have a higher proliferative activity than p53negative epithelia (1,7,8).
Odontogenic keratocysts appear to have an epithelial
lining with an intrinsic growth potential and have a
marked tendency to recur. This suggests an increased
epithelial atypia (8,11-14).
Due to its sometimes aggressive, persistent
behaviour, some authors believe that odontogenic
keratocysts can be considered benign cystic tumors (12).
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Moreover, in some cases of odontogenic keratocyst,
epithelial dysplasia is present and it seems that
keratinising cysts have a greater tendency for malignant
transformation (11,12).
The biological features of the cyst epithelium may be
related to recurrences: the mitotic index of odontogenic
keratocysts lining epithelial cells is greater than in other
types of odontogenic cysts (11-14).
Slootweg (13) and Li et al. (9) believe that differences
in the proliferative activity in odontogenic keratocysts
suggest an alteration in the cell’s cyle control with an
increase in cell proliferation that could explain the
biological behaviour of odontogenic keratocysts.
We detected the expression of p53 in 27 cases out of
40 using the monoclonal antibody which demonstrates
the accumulation of both wild-type and mutated p53
protein and produces a strong staining. In the present
study p53 was overexpressed more frequently in
odontogenic keratocysts than in other cysts.
Li et al. (9) found that the index of proliferation of
suprabasal cells of odontogenic keratocysts was
significantly higher (94.4+- 22.7) in proliferating cell
nuclear antigen positive (PCNA) cells/mm than in radicular
cysts (11.0 -+4.1 PCNA + cell/mm) and was similar to
that of oral mucosal epithelium (80.8 +- 20.6 PCNA +
cell/mm).
Toller (10) used radioactive labelling of cyst lining
explants to estimate mitotic activities, and found mean
labelling indices of 13% for keratocysts, 1.7% for nonkeratotic jaw cysts and 7% for human oral mucous
membrane.
The expression of p53 in many reactive lesions in
unlikely to be a consequence of gene mutation. Wild-type
p53
can
accumulate
and
be
determined
immunocytochemically in physiological processes such as
maturation of haemopoietic cells, DNA repair in
fibroblasts and rapidly proliferating lymphocytes (3,4).
Increased cellular proliferation has been shown to
result from the expression of defective p53 protein with
a subsequent greater risk of the perpetuation of mutation
and malignant transformation (5,7).
Slootweg (13) hypothesised that densely staining
p53-positive cells in odontogenic lesions are related to
increased proliferation.
Higher p53 positivity in radicular and dentigerous
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cysts can be explained by regenerative and degenerative
changes in the epithelial lining, which are related to
inflammations in these cysts.
In conclusion, the incidence of p53 protein nuclear
accumulation detected by immunohistochemistry is high
in odontogenic lesions. Additional research is needed to
highlight the relationship between p53 nuclear
accumulation and structural alterations as there seems to
be a possible discordance between the results of
immunohistochemistry and molecular genetic analyses.
Our results show a higher occurrence of p53 in
odontogenic keratocysts than in other jaw cysts. This
occurrence is strongly associated with the presence of

epithelial dysplasia in the cyst lining of odontogenic
keratocysts.
This needs further investigation because it could have
relevance to malignant transformation of the epithelial
lining in odontogenic keratocysts.
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